The SE is present in up to 80% of anti-cyclic citrullinated peptide 2 (anti-CCP2)-positive Caucasian patients with RA [8–10], in whom it is associated with increased binding of citrullinated peptides [11]. The gene discussed is AGBL2; the disease is rheumatoid arthritis.